We are live on ! Find out more
RXII

GALENA BIOPHARMA INC COM
RXII

Delisted

RXII was delisted on the 25th of October, 2011.

Back to rankings

60 hedge funds and large institutions have $29.3M invested in GALENA BIOPHARMA INC COM in 2013 Q2 according to their latest regulatory filings, with 60 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more call options, than puts

Call options by funds: $1.74M | Put options by funds: $1.2M

Holders
60
Holders Change
+60
Holders Change %
–
% of All Funds
1.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
60
Increased
–
Reduced
–
Closed
–
Calls
$1.74M
Puts
$1.2M
Net Calls
+$539K
Net Calls Change
+$539K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

RXII Hedge Fund Activity: Q2 2013 in Review

60 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in GALENA BIOPHARMA INC COM (RXII) for Q2 2013, worth a combined $29.3M.

Buyers outnumbered sellers: 60 funds opened new RXII positions and 0 closed out — a net gain of 60 holders — while 0 added to existing stakes and 0 trimmed.

  • 60 institutional investors held GALENA BIOPHARMA INC COM (RXII) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $29.3M of GALENA BIOPHARMA INC COM stock for Q2 2013.
  • 60 funds opened new GALENA BIOPHARMA INC COM positions in Q2 2013 and 0 closed out, a net change of +60 holders.

Based on aggregated 13F filings for Q2 2013.